Држава: Канада
Језик: Енглески
Извор: Health Canada
ORPHENADRINE CITRATE
VALEANT CANADA LP / VALEANT CANADA S.E.C.
M03BC01
ORPHENADRINE (CITRATE)
100MG
TABLET (EXTENDED-RELEASE)
ORPHENADRINE CITRATE 100MG
ORAL
8/100/500
OTC
MISCELLANEOUS SKELETAL MUSCLE RELAXANTS
Active ingredient group (AIG) number: 0102078001; AHFS:
CANCELLED POST MARKET
2014-07-30
(1) NORFLEX ® (ORPHENADRINE CITRATE ) Manufactured by: Medicis Pharmaceutical Corporation 7720 N. Dobson Road Scottsdale, AZ 85256 Distributed by: Medicis Canada Ltd., Toronto, Ontario M5V 1Y6 Canada Date of Preparation: January 3, 2012 CONTROL # 152408, 152409 (2) FACT SHEET Norflex® Tablets and Injectable Generic/Non-proprietary name: Orphenadrine Citrate Brand/Proprietary name: Norflex® Manufacturer: Medicis Pharmaceutical Corporation Chemical Name and Composition: Tablets, 100 mg. Injectable, 60 mg/ampule. N,N-Dimethyl-2-[(O-methyl-α-phenylbenzyl) oxy] ethylamine citrate (or, the citric acid salt of orphenadrine, [2-dimethyl-aminoethyl 2- methylbenzhydryl ether]) C 24 H 31 NO 8 Structural Formula: Molecular Weight: 461,57 Pharmacologic Classification: “Skeletal muscle relaxant” Structurally Related Drugs: Diphenhydramine analogues What Drug is Considered Standard: Mephenesin Physical Properties: The pure drug substance is a white, crystalline powder having a bitter taste and practically no odour. Macroscopic Appearance: Tablet – A white tablet, 11/32” diameter, standard cup Solubility: Water: Alcohol: Chloroform: Ether: Sparingly soluble Slightly soluble Insoluble Insoluble (3) Dye Content: None Carbohydrate Content: Tablets – 169 mg lactose Injectable – None Sodium Content: Tablets – None Injectable – 2.9 mg NaCl per mL 1.0 mg Sodium Bisulfide per mL NaOH as needed to buffer to 5.5 pH Stability: Recommended Storage Conditions: Tablets: Preserve in tight, light resistant containers. Store at room temperature (below 30°C). Injectable: Preserve in original ampule. Store at room temperature (below 30 °C). Shelf Life (Expiration Dating): Under Above Conditions: Tablets: 5 ½ years Injectable: 5 ½ years Site and Mechanism of Action: Orphenadrine is a centrally acting (brain stem) compound which selectively blocks facilitatory functions of the reticular formation. Site of Absorption: Tablets: Primarily small bowel. Onset of Action: Tablets – Following a single oral dose of Norflex, onset of Прочитајте комплетан документ